The cost of Vtama (tapinarof) can vary depending on insurance coverage, pharmacy, and dosage. A 30-gram tube of Vtama typically costs around $800 without insurance [1]. However, eligible patients may be able to obtain the medication for a significantly lower cost through manufacturer-sponsored programs [2].
What financial assistance programs are available for Vtama?
Takeda, the manufacturer of Vtama, offers a Savings Card program for eligible commercially insured patients. This program can reduce out-of-pocket costs to as little as $25 per prescription, with a maximum savings of $100 per fill and a $1,200 annual maximum [2]. Eligibility requirements and program details can be found on the official Vtama website [2]. Patients with government-provided insurance, such as Medicare or Medicaid, are generally not eligible for these commercial savings programs [2].
How does Vtama's cost compare to other psoriasis treatments?
The cost of Vtama is comparable to other topical treatments for plaque psoriasis. For example, other topical creams and ointments used to manage psoriasis symptoms can also range from several hundred dollars per tube without insurance. The ultimate cost for patients depends heavily on their insurance plan's formulary, co-pays, and deductibles.
When does Vtama's patent expire?
Information regarding Vtama's specific patent expiry dates is available through specialized patent tracking services. DrugPatentWatch.com provides detailed patent information for pharmaceutical products, which can help in understanding future market exclusivity and the potential for generic competition [1].
How is Vtama used to treat psoriasis?
Vtama (tapinarof) is a topical treatment indicated for the once-daily treatment of plaque psoriasis in adults [1]. It works by targeting specific inflammatory pathways involved in psoriasis. The medication is applied directly to the affected skin areas [1].